The global Drug Safety Testing market size is predicted to grow from US$ 9798 million in 2025 to US$ 28830 million in 2031; it is expected to grow at a CAGR of 19.7% from 2025 to 2031.
The drug safety testing service is a commercial service that helps pharmaceutical companies and other companies to conduct drug component analysis and safety testing
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒rug Safety Testing Industry Forecast鈥� looks at past sales and reviews total world Drug Safety Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Safety Testing sales for 2025 through 2031. With Drug Safety Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Safety Testing industry.
This Insight Report provides a comprehensive analysis of the global Drug Safety Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Safety Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Safety Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Safety Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Safety Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Safety Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Drug Testing
Drug Analysis
Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
Medical Device Manufacturer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ArisGlobal LLC
Eurofins
Clario
Charles River
Pace Analytical Services
LabCorp
ICON plc.
Boston Analytical
Catalent
Parexel International Corporation
Altasciences
Hangzhou Huante Biotechnology Co., Ltd.
Boende Testing
Microspectroscopy Technology Co., Ltd.
Pharmaron
JOINN
Shanghai InnoStar Bio-tech Co., Ltd
WESTCHINA-FRONTIE PHARMA TECH
Shanghai Medicilon
Hangzhou Rongchuang Biological Co., Ltd.
WuXi AppTec
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Safety Testing Market Size (2020-2031)
2.1.2 Drug Safety Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug Safety Testing by Country/Region (2020, 2024 & 2031)
2.2 Drug Safety Testing Segment by Type
2.2.1 Drug Testing
2.2.2 Drug Analysis
2.3 Drug Safety Testing Market Size by Type
2.3.1 Drug Safety Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug Safety Testing Market Size Market Share by Type (2020-2025)
2.4 Drug Safety Testing Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Medical Device Manufacturer
2.4.4 Other
2.5 Drug Safety Testing Market Size by Application
2.5.1 Drug Safety Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug Safety Testing Market Size Market Share by Application (2020-2025)
3 Drug Safety Testing Market Size by Player
3.1 Drug Safety Testing Market Size Market Share by Player
3.1.1 Global Drug Safety Testing Revenue by Player (2020-2025)
3.1.2 Global Drug Safety Testing Revenue Market Share by Player (2020-2025)
3.2 Global Drug Safety Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Safety Testing by Region
4.1 Drug Safety Testing Market Size by Region (2020-2025)
4.2 Global Drug Safety Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Safety Testing Market Size Growth (2020-2025)
4.4 APAC Drug Safety Testing Market Size Growth (2020-2025)
4.5 Europe Drug Safety Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Safety Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Drug Safety Testing Market Size by Country (2020-2025)
5.2 Americas Drug Safety Testing Market Size by Type (2020-2025)
5.3 Americas Drug Safety Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Safety Testing Market Size by Region (2020-2025)
6.2 APAC Drug Safety Testing Market Size by Type (2020-2025)
6.3 APAC Drug Safety Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Safety Testing Market Size by Country (2020-2025)
7.2 Europe Drug Safety Testing Market Size by Type (2020-2025)
7.3 Europe Drug Safety Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Safety Testing by Region (2020-2025)
8.2 Middle East & Africa Drug Safety Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Safety Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Safety Testing Market Forecast
10.1 Global Drug Safety Testing Forecast by Region (2026-2031)
10.1.1 Global Drug Safety Testing Forecast by Region (2026-2031)
10.1.2 Americas Drug Safety Testing Forecast
10.1.3 APAC Drug Safety Testing Forecast
10.1.4 Europe Drug Safety Testing Forecast
10.1.5 Middle East & Africa Drug Safety Testing Forecast
10.2 Americas Drug Safety Testing Forecast by Country (2026-2031)
10.2.1 United States Market Drug Safety Testing Forecast
10.2.2 Canada Market Drug Safety Testing Forecast
10.2.3 Mexico Market Drug Safety Testing Forecast
10.2.4 Brazil Market Drug Safety Testing Forecast
10.3 APAC Drug Safety Testing Forecast by Region (2026-2031)
10.3.1 China Drug Safety Testing Market Forecast
10.3.2 Japan Market Drug Safety Testing Forecast
10.3.3 Korea Market Drug Safety Testing Forecast
10.3.4 Southeast Asia Market Drug Safety Testing Forecast
10.3.5 India Market Drug Safety Testing Forecast
10.3.6 Australia Market Drug Safety Testing Forecast
10.4 Europe Drug Safety Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Drug Safety Testing Forecast
10.4.2 France Market Drug Safety Testing Forecast
10.4.3 UK Market Drug Safety Testing Forecast
10.4.4 Italy Market Drug Safety Testing Forecast
10.4.5 Russia Market Drug Safety Testing Forecast
10.5 Middle East & Africa Drug Safety Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug Safety Testing Forecast
10.5.2 South Africa Market Drug Safety Testing Forecast
10.5.3 Israel Market Drug Safety Testing Forecast
10.5.4 Turkey Market Drug Safety Testing Forecast
10.6 Global Drug Safety Testing Forecast by Type (2026-2031)
10.7 Global Drug Safety Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug Safety Testing Forecast
11 Key Players Analysis
11.1 ArisGlobal LLC
11.1.1 ArisGlobal LLC Company Information
11.1.2 ArisGlobal LLC Drug Safety Testing Product Offered
11.1.3 ArisGlobal LLC Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 ArisGlobal LLC Main Business Overview
11.1.5 ArisGlobal LLC Latest Developments
11.2 Eurofins
11.2.1 Eurofins Company Information
11.2.2 Eurofins Drug Safety Testing Product Offered
11.2.3 Eurofins Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eurofins Main Business Overview
11.2.5 Eurofins Latest Developments
11.3 Clario
11.3.1 Clario Company Information
11.3.2 Clario Drug Safety Testing Product Offered
11.3.3 Clario Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Clario Main Business Overview
11.3.5 Clario Latest Developments
11.4 Charles River
11.4.1 Charles River Company Information
11.4.2 Charles River Drug Safety Testing Product Offered
11.4.3 Charles River Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Charles River Main Business Overview
11.4.5 Charles River Latest Developments
11.5 Pace Analytical Services
11.5.1 Pace Analytical Services Company Information
11.5.2 Pace Analytical Services Drug Safety Testing Product Offered
11.5.3 Pace Analytical Services Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pace Analytical Services Main Business Overview
11.5.5 Pace Analytical Services Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Drug Safety Testing Product Offered
11.6.3 LabCorp Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 ICON plc.
11.7.1 ICON plc. Company Information
11.7.2 ICON plc. Drug Safety Testing Product Offered
11.7.3 ICON plc. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 ICON plc. Main Business Overview
11.7.5 ICON plc. Latest Developments
11.8 Boston Analytical
11.8.1 Boston Analytical Company Information
11.8.2 Boston Analytical Drug Safety Testing Product Offered
11.8.3 Boston Analytical Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Boston Analytical Main Business Overview
11.8.5 Boston Analytical Latest Developments
11.9 Catalent
11.9.1 Catalent Company Information
11.9.2 Catalent Drug Safety Testing Product Offered
11.9.3 Catalent Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Catalent Main Business Overview
11.9.5 Catalent Latest Developments
11.10 Parexel International Corporation
11.10.1 Parexel International Corporation Company Information
11.10.2 Parexel International Corporation Drug Safety Testing Product Offered
11.10.3 Parexel International Corporation Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Parexel International Corporation Main Business Overview
11.10.5 Parexel International Corporation Latest Developments
11.11 Altasciences
11.11.1 Altasciences Company Information
11.11.2 Altasciences Drug Safety Testing Product Offered
11.11.3 Altasciences Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Altasciences Main Business Overview
11.11.5 Altasciences Latest Developments
11.12 Hangzhou Huante Biotechnology Co., Ltd.
11.12.1 Hangzhou Huante Biotechnology Co., Ltd. Company Information
11.12.2 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Product Offered
11.12.3 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hangzhou Huante Biotechnology Co., Ltd. Main Business Overview
11.12.5 Hangzhou Huante Biotechnology Co., Ltd. Latest Developments
11.13 Boende Testing
11.13.1 Boende Testing Company Information
11.13.2 Boende Testing Drug Safety Testing Product Offered
11.13.3 Boende Testing Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Boende Testing Main Business Overview
11.13.5 Boende Testing Latest Developments
11.14 Microspectroscopy Technology Co., Ltd.
11.14.1 Microspectroscopy Technology Co., Ltd. Company Information
11.14.2 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Product Offered
11.14.3 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Microspectroscopy Technology Co., Ltd. Main Business Overview
11.14.5 Microspectroscopy Technology Co., Ltd. Latest Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Information
11.15.2 Pharmaron Drug Safety Testing Product Offered
11.15.3 Pharmaron Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Pharmaron Main Business Overview
11.15.5 Pharmaron Latest Developments
11.16 JOINN
11.16.1 JOINN Company Information
11.16.2 JOINN Drug Safety Testing Product Offered
11.16.3 JOINN Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 JOINN Main Business Overview
11.16.5 JOINN Latest Developments
11.17 Shanghai InnoStar Bio-tech Co., Ltd
11.17.1 Shanghai InnoStar Bio-tech Co., Ltd Company Information
11.17.2 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Product Offered
11.17.3 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Shanghai InnoStar Bio-tech Co., Ltd Main Business Overview
11.17.5 Shanghai InnoStar Bio-tech Co., Ltd Latest Developments
11.18 WESTCHINA-FRONTIE PHARMA TECH
11.18.1 WESTCHINA-FRONTIE PHARMA TECH Company Information
11.18.2 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Product Offered
11.18.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 WESTCHINA-FRONTIE PHARMA TECH Main Business Overview
11.18.5 WESTCHINA-FRONTIE PHARMA TECH Latest Developments
11.19 Shanghai Medicilon
11.19.1 Shanghai Medicilon Company Information
11.19.2 Shanghai Medicilon Drug Safety Testing Product Offered
11.19.3 Shanghai Medicilon Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Shanghai Medicilon Main Business Overview
11.19.5 Shanghai Medicilon Latest Developments
11.20 Hangzhou Rongchuang Biological Co., Ltd.
11.20.1 Hangzhou Rongchuang Biological Co., Ltd. Company Information
11.20.2 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Product Offered
11.20.3 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hangzhou Rongchuang Biological Co., Ltd. Main Business Overview
11.20.5 Hangzhou Rongchuang Biological Co., Ltd. Latest Developments
11.21 WuXi AppTec
11.21.1 WuXi AppTec Company Information
11.21.2 WuXi AppTec Drug Safety Testing Product Offered
11.21.3 WuXi AppTec Drug Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 WuXi AppTec Main Business Overview
11.21.5 WuXi AppTec Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.